Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass

Simone Renner, Werner Römisch-Margl, Cornelia Prehn, Stefan Krebs, Jerzy Adamski, Burkhard Göke, Helmut Blum, Karsten Suhre, Adelbert A. Roscher, Eckhard Wolf

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Diabetes is generally diagnosed too late. Therefore, biomarkers indicating early stages of β-cell dysfunction and mass reduction would facilitate timely counteraction. Transgenic pigs expressing a dominant-negative glucose-dependent insulinotropic polypeptide receptor (GIPR dn) reveal progressive deterioration of glucose control and reduction of β-cell mass, providing a unique opportunity to study metabolic changes during the prediabetic period. Plasma samples from intravenous glucose tolerance tests of 2.5- and 5-month-old GIPR dn transgenic and control animals were analyzed for 163 metabolites by targeted mass spectrometry. Analysis of variance revealed that 26 of 163 parameters were influenced by the interaction Genotype X Age (P ≤ 0.0001) and thus are potential markers for progression within the prediabetic state. Among them, the concentrations of seven amino acids (Phe, Orn, Val, xLeu, His, Arg, and Tyr) were increased in 2.5-month-old but decreased in 5-month-old GIPR dn transgenic pigs versus controls. Furthermore, specific sphingomyelins, diacylglycerols, and ether phospholipids were decreased in plasma of 5-month-old GIPR dntransgenic pigs. Alterations in plasma metabolite concentrations were associated with liver transcriptome changes in relevant pathways. The concentrations of a number of plasma amino acids and lipids correlated significantly with β-cell mass of 5-monthold pigs. These metabolites represent candidate biomarkers of early phases of β-cell dysfunction and mass reduction.

Original languageEnglish
Pages (from-to)2166-2175
Number of pages10
JournalDiabetes
Volume61
Issue number8
DOIs
Publication statusPublished - Aug 2012
Externally publishedYes

Fingerprint

Incretins
Swine
Lipids
Amino Acids
Phospholipid Ethers
Biomarkers
Prediabetic State
Genetically Modified Animals
Sphingomyelins
Diglycerides
Glucose Tolerance Test
Transcriptome
Mass Spectrometry
Analysis of Variance
Genotype
Glucose
Liver

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass. / Renner, Simone; Römisch-Margl, Werner; Prehn, Cornelia; Krebs, Stefan; Adamski, Jerzy; Göke, Burkhard; Blum, Helmut; Suhre, Karsten; Roscher, Adelbert A.; Wolf, Eckhard.

In: Diabetes, Vol. 61, No. 8, 08.2012, p. 2166-2175.

Research output: Contribution to journalArticle

Renner, S, Römisch-Margl, W, Prehn, C, Krebs, S, Adamski, J, Göke, B, Blum, H, Suhre, K, Roscher, AA & Wolf, E 2012, 'Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass', Diabetes, vol. 61, no. 8, pp. 2166-2175. https://doi.org/10.2337/db11-1133
Renner, Simone ; Römisch-Margl, Werner ; Prehn, Cornelia ; Krebs, Stefan ; Adamski, Jerzy ; Göke, Burkhard ; Blum, Helmut ; Suhre, Karsten ; Roscher, Adelbert A. ; Wolf, Eckhard. / Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass. In: Diabetes. 2012 ; Vol. 61, No. 8. pp. 2166-2175.
@article{08449d229b294c099fc04708b2bd185a,
title = "Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass",
abstract = "Diabetes is generally diagnosed too late. Therefore, biomarkers indicating early stages of β-cell dysfunction and mass reduction would facilitate timely counteraction. Transgenic pigs expressing a dominant-negative glucose-dependent insulinotropic polypeptide receptor (GIPR dn) reveal progressive deterioration of glucose control and reduction of β-cell mass, providing a unique opportunity to study metabolic changes during the prediabetic period. Plasma samples from intravenous glucose tolerance tests of 2.5- and 5-month-old GIPR dn transgenic and control animals were analyzed for 163 metabolites by targeted mass spectrometry. Analysis of variance revealed that 26 of 163 parameters were influenced by the interaction Genotype X Age (P ≤ 0.0001) and thus are potential markers for progression within the prediabetic state. Among them, the concentrations of seven amino acids (Phe, Orn, Val, xLeu, His, Arg, and Tyr) were increased in 2.5-month-old but decreased in 5-month-old GIPR dn transgenic pigs versus controls. Furthermore, specific sphingomyelins, diacylglycerols, and ether phospholipids were decreased in plasma of 5-month-old GIPR dntransgenic pigs. Alterations in plasma metabolite concentrations were associated with liver transcriptome changes in relevant pathways. The concentrations of a number of plasma amino acids and lipids correlated significantly with β-cell mass of 5-monthold pigs. These metabolites represent candidate biomarkers of early phases of β-cell dysfunction and mass reduction.",
author = "Simone Renner and Werner R{\"o}misch-Margl and Cornelia Prehn and Stefan Krebs and Jerzy Adamski and Burkhard G{\"o}ke and Helmut Blum and Karsten Suhre and Roscher, {Adelbert A.} and Eckhard Wolf",
year = "2012",
month = "8",
doi = "10.2337/db11-1133",
language = "English",
volume = "61",
pages = "2166--2175",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass

AU - Renner, Simone

AU - Römisch-Margl, Werner

AU - Prehn, Cornelia

AU - Krebs, Stefan

AU - Adamski, Jerzy

AU - Göke, Burkhard

AU - Blum, Helmut

AU - Suhre, Karsten

AU - Roscher, Adelbert A.

AU - Wolf, Eckhard

PY - 2012/8

Y1 - 2012/8

N2 - Diabetes is generally diagnosed too late. Therefore, biomarkers indicating early stages of β-cell dysfunction and mass reduction would facilitate timely counteraction. Transgenic pigs expressing a dominant-negative glucose-dependent insulinotropic polypeptide receptor (GIPR dn) reveal progressive deterioration of glucose control and reduction of β-cell mass, providing a unique opportunity to study metabolic changes during the prediabetic period. Plasma samples from intravenous glucose tolerance tests of 2.5- and 5-month-old GIPR dn transgenic and control animals were analyzed for 163 metabolites by targeted mass spectrometry. Analysis of variance revealed that 26 of 163 parameters were influenced by the interaction Genotype X Age (P ≤ 0.0001) and thus are potential markers for progression within the prediabetic state. Among them, the concentrations of seven amino acids (Phe, Orn, Val, xLeu, His, Arg, and Tyr) were increased in 2.5-month-old but decreased in 5-month-old GIPR dn transgenic pigs versus controls. Furthermore, specific sphingomyelins, diacylglycerols, and ether phospholipids were decreased in plasma of 5-month-old GIPR dntransgenic pigs. Alterations in plasma metabolite concentrations were associated with liver transcriptome changes in relevant pathways. The concentrations of a number of plasma amino acids and lipids correlated significantly with β-cell mass of 5-monthold pigs. These metabolites represent candidate biomarkers of early phases of β-cell dysfunction and mass reduction.

AB - Diabetes is generally diagnosed too late. Therefore, biomarkers indicating early stages of β-cell dysfunction and mass reduction would facilitate timely counteraction. Transgenic pigs expressing a dominant-negative glucose-dependent insulinotropic polypeptide receptor (GIPR dn) reveal progressive deterioration of glucose control and reduction of β-cell mass, providing a unique opportunity to study metabolic changes during the prediabetic period. Plasma samples from intravenous glucose tolerance tests of 2.5- and 5-month-old GIPR dn transgenic and control animals were analyzed for 163 metabolites by targeted mass spectrometry. Analysis of variance revealed that 26 of 163 parameters were influenced by the interaction Genotype X Age (P ≤ 0.0001) and thus are potential markers for progression within the prediabetic state. Among them, the concentrations of seven amino acids (Phe, Orn, Val, xLeu, His, Arg, and Tyr) were increased in 2.5-month-old but decreased in 5-month-old GIPR dn transgenic pigs versus controls. Furthermore, specific sphingomyelins, diacylglycerols, and ether phospholipids were decreased in plasma of 5-month-old GIPR dntransgenic pigs. Alterations in plasma metabolite concentrations were associated with liver transcriptome changes in relevant pathways. The concentrations of a number of plasma amino acids and lipids correlated significantly with β-cell mass of 5-monthold pigs. These metabolites represent candidate biomarkers of early phases of β-cell dysfunction and mass reduction.

UR - http://www.scopus.com/inward/record.url?scp=84864300391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864300391&partnerID=8YFLogxK

U2 - 10.2337/db11-1133

DO - 10.2337/db11-1133

M3 - Article

VL - 61

SP - 2166

EP - 2175

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -